These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 95802)

  • 21. Glucose and insulin responses to oral glucose in overt non-insulin-dependent diabetics with and without the islet cell antibody.
    Gray RS; Irvine WJ; Cameron EH; Duncan LJ
    Diabetes; 1980 Apr; 29(4):312-6. PubMed ID: 6987121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoenzyme detection of autoantibodies to the surface of pancreatic islet cells in diabetes mellitus and in increased risk of its development].
    Kondrat'ev IuIu; Sadovnikova NV; Kuraeva TL; Shcherbacheva LN; Smirnova OM
    Probl Endokrinol (Mosk); 1987; 33(2):3-6. PubMed ID: 3299355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence & significance of pancreatic islet cell & adrenal antibodies in patients with Graves' disease.
    Goswami R; Srikanta SS; Kochupillai N
    Indian J Med Res; 1995 May; 101():201-6. PubMed ID: 7601498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for insulin-dependent diabetics?
    Rossini AA
    N Engl J Med; 1983 Feb; 308(6):333-5. PubMed ID: 6337326
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy to prevent type 1 diabetes mellitus.
    Carel JC; Landais P; Bougnères P
    N Engl J Med; 2002 Oct; 347(14):1115-6. PubMed ID: 12362017
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A; Manrique M; Arteaga A; Acosta AM; Andrade L
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
    Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K
    Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. The Belgian Diabetes Registry.
    Decraene T; Vandewalle C; Pipeleers D; Gorus FK
    Clin Chem; 1992 Sep; 38(9):1762-7. PubMed ID: 1526011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention strategy of beta-cell failure in ICA-positive NIDDM].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():765-8. PubMed ID: 9434561
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of anti-islet-antibody-positive patient treated with insulin plus calcitriol.
    Cetinkalp S; Hamulu F; Ozgen AG; Kavalali I; Kabalak T; Yilmaz C; Tüzün M
    Endocr J; 1999 Dec; 46(6):837-8. PubMed ID: 10724361
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
    Pontiroli AE; Calderara A; Maffi P; Bonisolli L; Carenini A; Piatti PM; Monti LD; Gallus G; Pozza G; Illeni MT
    Diabete Metab; 1989; 15(2):79-84. PubMed ID: 2661281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-obese adult onset diabetes with oral hypoglycemic agent failure: islet cell autoantibodies or reversible beta cell refractoriness?
    Sá JR; Silva RC; Nasri F; Aguade LC; Velloso L; Chacra AR; Dib SA
    Braz J Med Biol Res; 2003 Oct; 36(10):1301-9. PubMed ID: 14502361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet-cell antibodies in diabetes mellitus.
    Lendrum R; Walker G; Cudworth AG; Theophanides C; Pyke DA; Bloom A; Gamble DR
    Lancet; 1976 Dec; 2(7998):1273-6. PubMed ID: 63747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does knowledge of islet cell antibody status help in managing diabetes presenting in middle and old age?
    Gregory R; Tattersall RB
    Diabet Med; 1991 Jan; 8(1):72-5. PubMed ID: 1826249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine immune-mediated diabetes mellitus: a case report.
    Elie M; Hoenig M
    J Am Anim Hosp Assoc; 1995; 31(4):295-9. PubMed ID: 7552660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.
    MacCuish AC; Irvine WJ; Barnes EW; Duncan LJ
    Lancet; 1974 Dec; 2(7896):1529-31. PubMed ID: 4140978
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is induction of oral tolerance to to insulin a suitable treatment concept in therapy of type I diabetes mellitus?].
    Marth T; Stallmach A
    Z Gastroenterol; 2001 May; 39(5):437-9. PubMed ID: 11413918
    [No Abstract]   [Full Text] [Related]  

  • 39. Transplacental passage of islet cell antibody in infants of diabetic mothers.
    Tingle AJ; Lim G; Wright VJ; Dimmick JE; Hunt JA
    Pediatr Res; 1979 Dec; 13(12):1323-5. PubMed ID: 392429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.
    Del Prete GF; Betterle C; Padovan D; Erle G; Toffolo A; Bersahi G
    Diabetes; 1977 Oct; 26(10):909-15. PubMed ID: 332567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.